We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hyperthermic Treatment with Carbon Nanotubes Kills Breast Cancer Stem Cells

By LabMedica International staff writers
Posted on 01 Mar 2012
Hyperthermic treatment of breast tumors with multiwall carbon nanotubes (MWCNTs) has been found to kill both differentiated cancer cells and the breast cancer-stem cells that drive tumor growth and recurrence.

Breast tumors contain a small population of tumor initiating stem-like cells, termed breast cancer-stem cells (BCSCs). More...
These cells, which are refractory to chemotherapy and radiotherapy, are thought to persist following treatment and drive tumor recurrence.

Having successfully used MWCNTs to treat breast tumors in a mouse model, investigators at Wake Forest Baptist Medical Center (Winston-Salem, NC, USA) examined their effect on. To this end, they worked with a mouse breast-cancer model. Tumors containing BCSCs were injected with nanotubes, which were then exposed to laser-generated, near-infrared radiation. The nanotubes vibrated, creating local areas of high temperature.

Results published in the April 2012 online edition of the journal Biomaterials revealed that that despite being markedly resistant to traditional hyperthermia BCSCs were sensitive to nanotube-mediated thermal treatment and lost their long-term proliferative capacity. Moreover, use of this therapy in vivo promoted complete tumor regression and long-term survival of mice bearing cancer stem cell-driven breast tumors.

The investigators speculated that nanotube thermal therapy promoted rapid membrane permeabilization and necrosis of the BCSCs. Destruction of the BCSCs prevented recurrence of the tumor.

“They are tough. These are cells that do not divide very often. They just sort of sit there, but when they receive some sort of trigger – and that is not really well understood – it is believed they can migrate to other sites and start a metastasis somewhere else,” said senior author Dr. Suzy Torti, professor of biochemistry at Wake Forest Baptist Medical Center. “Heat-based cancer treatments represent a promising approach for the clinical management of cancers, including breast cancer.”

“To truly cure a cancer, you have to get rid of the entire tumor, including the small population of cancer stem cells that could give rise to metastasis,” said Dr. Torti. “There is more research to be done. We are looking at five to 10 years of more study and development. But what this study shows is that all that effort may be worth it – it gives us a direction to go for a cure.”

Related Links:

Wake Forest Baptist Medical Center




New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Alcohol Testing Device
Dräger Alcotest 7000
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: An innovative deep learning model can accurately predict MSI tumor and immune checkpoint inhibitor responsiveness (Photo courtesy of Jae-Ho Cheong/Yonsei University College of Medicine)

AI Model Accurately Predicts MSI Tumor and Immune Checkpoint Inhibitor Responsiveness

One in three people is expected to develop cancer in their lifetime, and a key factor in patient prognosis is the tumor’s microsatellite status—whether it is stable or shows microsatellite instability-high (MSI-H).... Read more

Pathology

view channel
Image: Virtual staining of label-free tissue in imaging mass spectrometry (Photo courtesy of Ozcan Lab/UCLA)

Deep Learning Advances Imaging Mass Spectrometry with Virtual Histological Detail

Imaging mass spectrometry (IMS) is a powerful technique that can map thousands of molecular species in biological tissues with exceptional chemical specificity. However, IMS is hindered by relatively low... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.